Streetbeat News

Revenues

DXR

Daxor Corporation (NASDAQ:DXR) has announced the acquisition of exclusive rights to Volumex, Megatope, and Glofil from Iso-Tex Diagnostics, Inc. This move is expected to enhance Daxor's diagnostics suite, improve margins, and create new revenue streams. The acquisitions are projected to be cash flow positive and accretive to earnings immediately. The manufacturing will be moved in-house to Daxor's Oak Ridge facility, with payments for the transaction spread over two years after a 6-9 month transition period. The deal is pending regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:11 pm

BTM

Bitcoin Depot announced its expectation for Q1 consolidated revenue to be between $137M-$138M, which is below the estimated $167.74M. This indicates a potential shortfall in revenue compared to market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:08 pm

MNDY

Monday.Com (NASDAQ:MNDY) has been analyzed by 12 analysts, showing a shift towards a more bullish outlook with an increase in the average price target to $245.00 from $225.43. Analysts from firms like JP Morgan and Tigress Financial have raised their price targets, reflecting optimism about the company's future performance. Monday.Com's financial indicators such as revenue growth and net margin are strong, but its ROE is below industry averages. The company's market positioning and operational scale are also discussed, highlighting its global presence and innovative platform.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 12:01 pm

BIGC

BigCommerce Holdings (NASDAQ:BIGC) has been evaluated by 5 analysts over the last three months, showing a mix of opinions. The average 12-month price target is now $11.0, up 1.1% from the previous $10.88, with a high estimate of $20.00 and a low of $7.50. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. BigCommerce's financials show a solid revenue growth rate of 16.18% as of December 31, 2023, but lag behind industry peers. The company's net margin outperforms industry averages, yet it faces challenges with a high debt-to-equity ratio and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 12:01 pm

CNC

Five analysts have recently updated their ratings on Centene (NYSE:CNC), showing a mix of sentiments but overall a slight positive shift with an increase in the average 12-month price target to $91.00 from $89.00. The ratings range from 'Equal-Weight' to 'Overweight', with price target adjustments reflecting analysts' reactions to market conditions and Centene's performance. Centene, a managed-care organization, has shown notable revenue growth and financial health, outperforming industry averages in net margin, ROE, and ROA, despite a higher debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 12:00 pm

AEHR

Aehr reported preliminary Q3 revenue of $7.6M, significantly below the $14.32M estimate, and an adjusted EPS loss of $(0.03)-$(0.04), contrary to the expected $0.13. For FY24, Aehr anticipates revenue of $65M, below the $77.41M estimate, with an adjusted EPS of $0.48 versus the expected $0.77. The company also expects a GAAP net loss for Q3 but projects a GAAP net income for the full fiscal year.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:46 am

TMCI

Treace Medical Concepts has reached a significant milestone by treating 100,000 patients with its patented Lapiplasty 3D Bunion Correction System, showcasing the system's acceptance and effectiveness in the medical community.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:09 am

IR

Ingersoll Rand has agreed to acquire ILC Dover from New Mountain Capital, LLC, for approximately $2.325 billion. The acquisition is expected to be immediately accretive to Ingersoll Rand's Precision and Science Technologies segment, with an upfront purchase multiple of about 17x 2024E Adjusted EBITDA. ILC Dover brings new technologies for life science applications, expands Ingersoll Rand's addressable market by over $10 billion, and increases access to life science solutions in various end markets.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:08 am

TSLA

Tesla Inc (NASDAQ:TSLA) bear Gordon Johnson speculates that Tesla's announced price hikes in the U.S., Europe, and China might indicate a planned reduction in production volumes, similar to recent cuts in China. This speculation arises amidst reports of Tesla increasing prices for its Model Y vehicles in these regions and reducing production at its Shanghai gigafactory. Tesla bull Ross Gerber views the production cut as a response to the Chinese recession, affecting several companies, including Tesla. Tesla shares closed down 1.15% on Friday, with a 31.23% decrease year-to-date.

Portfolio Pulse from Anan Ashraf

March 25, 2024 | 11:00 am

AMD

INTC

Shares of AMD and Intel are trading lower following China's announcement of new guidelines to phase out their microprocessors in government PCs and servers. This move is likely to impact the companies' market share and revenues in one of the largest markets.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 10:58 am